Hepatitis C and beta-thalassemia major in children: experience with glecaprevir/pibrentasvir

被引：0

作者：

Quintero Garcia, Diannet ^{[1
]}

Sebastian Cuevas, Francisco Jose ^{[1
]}

Crehua Gaudiza, Elena ^{[1
]}

机构：

[1] Hosp Clin Univ Valencia, Dept Pediat, Valencia, Spain

来源：

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS | 2021年 / 113卷 / 02期

关键词：

Children; Hepatitis C virus; Beta-thalassemia major; Cirrhosis; Glecaprevir/pibrentasvir;

D O I：

10.17235/reed.2020.7092/2020

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Hepatitis C virus (HCV) is estimated to affect 3.26 million children worldwide, with the highest number of cases registered in Pakistan and China. Vertical transmission is the principal route in industrialized countries. However, iatrogenic transmission is relevant in low-income settings. We present the case of a 12-year-old Pakistani child who suffered from beta-thalassemia major and hepatitis C, successfully treated with glecaprevir/pibrentasvir.

引用

页码：150 / +

页数：2

共 6 条

[1] Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH) [J].

Crespo, Javier ;

Albillos, Agustin ;

Buti, Maria ;

Luis Calleja, Jose ;

Garcia Samaniego, Javier ;

Hernandez Guerra, Manuel ;

Serrano, Trinidad ;

Turnes, Juan ;

Acin, Enrique ;

Berenguer, Juan ;

Berenguer, Marina ;

Colom, Joan ;

Fernandez, Inmaculada ;

Fernandez Rodriguez, Conrado ;

Forns, Xavier ;

Garcia, Federico ;

Granados, Rafael ;

Lazarus, Jeffrey ;

Maria Molero, Jose ;

Molina, Esther ;

Perez Escanilla, Fernando ;

Pineda, Juan A. ;

Rodriguez, Manuel ;

Romero, Manuel ;

Roncero, Carlos ;

Saiz de la Hoya, Pablo ;

Sanchez Antolin, Gloria .

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2019, 111 (11) :862-873

[2]

Indolfi G, 2019, LANCET GASTROENTEROL, V4, P477, DOI 10.1016/S2468-1253(19)30046-9

[3]

Jonas MM, 2019, HEPATOLOGY, DOI [10.1002/hep.30840/suppinfo, 10.1002/hep.30840]

[4] The Course of Hepatitis C Infection and Response to Anti-viral Therapy in Patients with Thalassemia major and Hepatitis C Infection: A Longitudinal, Prospective Study [J].

Kamal, Sanaa ;

Abdelhakam, Sara ;

Ghoraba, Dalia ;

Mohsen, Mohamed Amer ;

Salam, Ahmed Abdel ;

Hassan, Hoda ;

Nabeigh, Leila .

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2019, 11

[5]

O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI [10.1086/344188, 10.1086/502007]

[6] Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial [J].

Wyles, David ;

Poordad, Fred ;

Wang, Stanley ;

Alric, Laurent ;

Felizarta, Franco ;

Kwo, Paul Y. ;

Maliakkal, Benedict ;

Agarwal, Kosh ;

Hassanein, Tarek ;

Weilert, Frank ;

Lee, Samuel S. ;

Kort, Jens ;

Lovell, Sandra S. ;

Liu, Ran ;

Lin, Chih-Wei ;

Pilot-Matias, Tami ;

Krishnan, Preethi ;

Mensa, Federico J. .

HEPATOLOGY, 2018, 67 (02) :514-523

← 1 →